Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that it will present new data from its Alzheimer’s disease portfolio at the Alzheimer’s Association International ...
Alzheimer’s disease slowly strips brain cells of the energy they need to survive. However, one damaged enzyme may be doing more of that work than anyone realized.
The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial ...
Researchers at the FAMU-FSU College of Engineering and the National High Magnetic Field Laboratory have shown how higher ...
Growing evidence suggests that the key to treating Alzheimer's is catching it in its earliest stages. Now scientists have developed a promising new drug that seems to be effective at stalling the ...
Alzheimer's disease begins to weave a web in the brain and remodel neuronal tissue 15 to 20 years before the first symptoms appear. From the time this happens, however, until the disease is diagnosed ...
A chemical called 6PPD-quinone (6PPD-Q), which forms when shaved-off tire particles come into contact with ozone, might ...
18hon MSN
An anti-inflammatory diet may lower dementia risk, even in people with early signs of Alzheimer’s
Healthy eating may help protect the brain, even after early biological changes linked to Alzheimer’s disease have begun, a ...
As marijuana's potential health benefits are under debate, new research has found that THC could have a powerful and positive effect on the brain. Researchers at the University of Texas (UT) at San ...
PLAYING happily, Emily Feiler and Isabella Piper are unaware they have a rare brain disorder. It will see them develop ...
Five oral presentations in a Featured Research Session will highlight trontinemab, including new long-term data from Phase Ib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results